Clinical Trial Update: Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of valsartan/amlodipine combination and monotherapy in patients with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• VALSARTAN (Valsartan)
• Valsartan/amlodipine (Valsartan/amlodipine)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED